Outlook on the Proteomics Global Market to 2027 – Featuring Agilent Technologies, Bio-Rad Laboratories and Danaher Among Others – Yahoo Finance
Dublin, July 07, 2022 (GLOBE NEWSWIRE) — The “Proteomics Market – Global Outlook and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.
Proteomics is the extensive study of proteins. It is a rapidly growing field in disease diagnosis. Proteomics identifies disease-associated proteins and studies their function, structure, and expression. Proteomics researchers primarily rely on sophisticated technology to deliver actionable insights to advance the field because of the number of complexities in proteomics. Proteomics is a key tool in medical research because it makes it possible to study large-scale proteins from various biological samples to discover new protein biomarkers for different disease conditions.
Proteomics allows for discovering new protein biomarkers for diagnostic applications and the investigation of novel molecular targets for medication development and discovery. Protein expression profiling, targeted protein quantification, protein-protein interaction analysis, and post-translational modifications are all possible using proteomics. Proteomics has demonstrated its utility in biomarker identification, medication development, and precision medicine.
The following factors will drive the global proteomics market growth during the forecast period:
Increasing Number of Research and Development Activities in Proteomics
Rising Prevalence of Cancer and Various Genetic Disorders
Growing Focus on Development of Precision Medicine
Impact of COVID-19
The impact of COVID-19 is also seen in the proteomics market’s growth. There has been increased research on diagnostics, biomarker discovery, and drug discovery and development against COVID-19. It has accelerated the involvement of proteomics. Several large and small companies have constantly been coming up with immunoassay kits to detect COVID-19 rapidly. Along with companies, many public/private research organizations and research institutes also increased the research on the coronavirus involving the proteomics approach extensively.
Proteomics plays a considerable role in drug development, and therefore, many drug manufacturers have started their proteomics divisions that fuel the growth of the global proteomics market.
Existing technologies have several drawbacks, including a lack of specificity, especially in high-multiplex assays, a lack of sensitivity, and a lack of precision; a limited dynamic range (the ability to measure a wide range of concentrations reliably and simultaneously); a high sample consumption requirement; a lack of scalability; a low throughput; data complexity; and a high cost. This scenario is changing over time and will enhance the scope of proteomics.
Proteomics technologies in the market include spectrometry, microarray, chromatography, and reagents used for proteomic analysis. The majority of proteomic analysis primarily relies on an expensive and complex analysis of proteome complexity at the level of amino acid variants, which have the potential to generate important biological insights.
Nanoproteomics offers real-time multiplexed analysis, rapid and miniatured assay, low sample consumption, and high sensitivity, thereby finding many applications for proteomic investigations.
The growing prominence of nanoproteomics offers significant growth opportunities for players in the market. Nanoproteomics is still in its early stage of enabling broad biomedical applications. In the upcoming years, continuous technological advancement in this field is anticipated. The growing prominence of nanoproteomics offers significant growth opportunities for players in this market.
BGI, a China-based company, has extensive experience in nanoproteomics. The company offers a nanoproteomics service, serving in more than 66 countries. Seer company’s photograph product suite, an integrated solution, consists of the company’s proprietary engineered nanoparticles, consumables, automation instrument, and software that allows proteomics studies. It reduces the complexity of traditional proteomics. It has commercialized its services using the proteograph product suite with North America, Europe, and the Asia Pacific providers.
Consumables & Reagent: Highest Revenue Contributor
The consumables and reagents segment has the largest market share accounting for 77.08% in 2021. For several decades, many companies have included both small and large companies, relentlessly working to bring more reagents and consumables used in all the areas of proteomics application in the initial step, which is during the sample preparation.
Many vital companies offer a wide range of consumables and reagents, such as Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific. An increase in the reagent’s portfolio is evitable with the increasing proteomics research worldwide. These factors make the consumables and reagents segment the highest revenue maker, with $19.37 billion in 2021.
The instruments and software market is to grow at a CAGR of 13% from 2022 to 2027.
Most key companies offer a wide range of instruments for microarray, spectrometry, chromatography, electrophoresis, surface plasma resonance, and x-ray crystallography. With the increasing research on biomarker discovery and drug discovery and development, several pharmaceutical companies and academic & research institutes are expected to increase the implementation of instruments and software in their laboratories. Hence, the instruments & software segment is expected to increase in the forecast period with a CAGR of 13%.
End-user Insights
Among all the end-users, the pharmaceutical and biotechnology companies segment is growing due to the development and demand of the increasing diagnostic for drug development. The surge in the use of proteomic technology is also due to the rising adoption of precision medicine driven by biomarkers identification and discovery in response to the increasing prevalence of chronic diseases such as cancer mainly.
Several academic and research institutes are also the second major revenue generator in the proteomics market, increasing research on developing drugs and vaccines. Hospitals are also using proteomics technologies for disease diagnosis purposes. They either have their in-house pathology laboratory or collaborate with a diagnostic laboratory, and they get the diagnosis done by sending the samples. In collaboration or partnership with proteomics companies, several hospitals are enabling the companies to develop related proteomic technologies.
Forensic laboratories are also contributing and accounting for a good market share in growing the proteomics markets by receiving massive funding and investments to conduct research in forensic science for protein identification and biomarker discovery.
Vendor Analysis
Vendors are divided into both manufacturers and service providers. The proteomics market is highly dynamic and competitive, with global, regional, and local players offering a wide range of proteomics solutions. Agilent Technologies, Bio-Rad Laboratories, Thermo-Fisher Scientific, Danaher, and PerkinElmer are the significant players in providing products in proteomics, whereas BGI Group is a substantial player in offering proteomics services.
Expansion activities (regional business and facility expansions) are helping players strengthen the global distribution networks and thus allowing the players to explore untapped opportunities.
Increasing product launches
Large scale investments in the single-use bioprocessing probes and sensors market through varied conglomerates and investments firms
Forging collaborations and partnerships with well-established manufacturers, academic & research institutes, hospitals, and diagnostic & forensic laboratories is cementing the players’ footprints.
Strategic acquisitions continue to be an essential competitive strategy for key players to expand their product offerings, access new technology, or increase market share.
In low and middle-income countries, the service providers are mainly in demand as these countries do lack proper healthcare infrastructure.
Service providers are focusing on increasing the collaborations with hospitals and several pharmaceutical companies to grow in the market.
The need for companies that provide proteomics services has drawn the attention of many researchers from laboratories that are not equipped with advanced technologies for proteomic research. This could be due to a lack of skilled professionals or in-house infrastructure, as increased demand for proteomics research. Many companies have emerged by providing protein identification, quantification, sequencing, purification, and custom assay services.
Key Questions Answered
1. How big is the global proteomics market?
2. What is the growth rate of the global proteomics market?
3. Who are the key players in the global proteomics market?
4. What are the growth factors in the global proteomics market?
5. What are the latest trends in the global proteomics market?
Key Topics Covered:
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of the Study
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 Increasing Prominence of Nanoproteomics
8.2 Developments in Mass Spectrometry-Based Proteomics
8.3 Prominent Role of Proteomics in Diabetes Management
9 Market Growth Enablers
9.1 Rising Number of R&D Projects in Proteomics
9.2 Increasing Prevalence of Cancer and Various Genetic Disorders
9.3 Growing Focus on Development of Precision Medicine
10 Market Restraints
10.1 Limitations Associated With Accessing Proteome
10.2 Dearth of Skilled Professionals
10.3 Strict Regulatory Norms & High Cost of Instruments
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Consumables & Reagents
12.4 Instruments & Software
12.5 Services
13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Drug Discovery & Development and Translational Research
13.4 Clinical Applications
13.5 Forensics & Applied Proteomics
14 End-user
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Pharmaceutical & Biotechnology Companies
14.4 Academic & Research Institutes
14.5 Hospitals
14.6 Diagnostic & Forensic Laboratories
15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview
16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 North America: Product Segmentation
16.4 North America: Application Segmentation
16.5 North America: End-User Segmentation
16.6 Key Countries
17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Europe: Product Segmentation
17.4 Europe: Application Segmentation
17.5 Europe: End-User Segmentation
17.6 Key Countries
18 Apac
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Apac: Product Segmentation
18.4 Apac: Application Segmentation
18.5 Apac: End-User Segmentation
18.6 Key Countries
19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Latin America: Product Segmentation
19.4 Latin America: Application Segmentation
19.5 Latin America: End-User Segmentation
19.6 Key Countries
20. Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Middle East & Africa: Product Segmentation
20.4 Middle East & Africa: Application Segmentation
20.5 Middle East & Africa: End-User Segmentation
20.6 Key Countries
21. Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis
22. Key Company Profiles
22.1 Agilent Technologies
22.2 Bio-Rad Laboratories
22.3 Danaher
22.4 Thermo Fisher Scientific
22.5 Perkinelmer
22.6 Bgi Group
23. Other Prominent Vendors – by Product
23.1 Bruker
23.2 Diasorin
23.3 Horiba
23.4 Illumina
23.5 Inoviq
23.6 Li-Cor Biosciences
23.7 Nautilus Biotechnology
23.8 Proteome Factory
23.9 Qiagen
23.10 Rhythm Biosciences
23.11 Shimadzu Scientific Instruments
23.12 Seer
23.13 Waters
24. Service Providers
24.1 Applied Biomics
24.2 Creative Proteomics
24.3 Poochon Scientific
24.4 Somalogic
24.5 Vproteomics
25. Product & Service Providers
25.1 Abcam
25.2 Anteotech
25.3 Ayoxxa Biosystems
25.4 Biognosys
25.5 Genei Laboratories
25.6 Grace Bio-Labs
25.7 Itsi-Biosciences
25.8 Msaid
25.9 Olink
25.10 Promega
25.11 Proteomics International
25.12 Quanterix
26. Report Summary
27. Quantitative Summary
28. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/63tdqk
Gas futures are falling as prices have already receded from recent highs.
The California-based tech giant finalized the purchase of about 750.6 acres of land for its semiconductor campus for around $111 million through its Growth Site LLC subsidiary, according to the Licking County Auditor. The purchase was split across two parcels, one on Clover Valley Road and one on Green Chapel Road.
(Bloomberg) — A Russian court order to halt oil loadings from a port in the Black Sea has unnerved European crude traders already reeling from the tightest regional market in years, sending prices for competing barrels spiraling.Most Read from BloombergUS Mortgage Rates Plunge to 5.3% in Biggest Drop Since 2008Tycoon Whose Bet Broke the Nickel Market Walks Away a BillionaireMusk Tweets About Underpopulation After Report He Fathered Twins With EmployeeBoris Johnson Odds: Who Are the Front-Runner
In this article, we talk about the 10 oil and gas stocks to buy according to billionaire Steve Cohen. If you wish to skip our detailed analysis of the energy sector and Cohen’s hedge fund history, go directly to 5 Oil and Gas Stocks to Buy According to Billionaire Steve Cohen. Because of the Russian […]
U.S. drivers had high hopes that the historic release of oil from the nation's Strategic Petroleum Reserve would help ease triple-digit prices of crude oil and reduce gasoline prices at the pump, but costs for both have seen little relief.
LONDON (Reuters) -Qatar Airways has indicated that a provisional agreement to buy up to 50 Boeing 737 MAX jets has lapsed, Boeing's rival Airbus said in a court document released on Thursday. The deal, signed in Washington in January, is part of a series of inter-locking agreements caught up in a London court dispute between Airbus and the Gulf carrier over a larger jet. Airbus requested a copy of the Boeing 737 MAX agreement after the airline brought it up as part of its bid for compensation for damage to the A350, now worth $1.4 billion.
Now the Energy Select Sector SPDR Fund (XLE) and the SPDR S&P Oil & Gas Exploration & Production (XOP) exchange-traded funds (ETFs) are down 27% to 36% from their 2022 peaks – official bear-market territory. Now three factors suggest another strong move ahead for energy names, believes Cook: decent underlying fundamentals, good valuations and solid cash flows. Goldman Sachs predicts large-cap energy stocks will gain 30% or more through the end of the year and that its buy-rated stocks could be up 40% or more.
The stock markets tumbled and a short-seller slammed Nio (NYSE: NIO) for fudging its numbers last month, but the electric vehicle (EV) stock still ended June with solid 24.9% gains, according to data provided by S&P Global Market Intelligence. A new product launch and big plans for the near future helped the stock bottom after its steep fall this year through May, and Nio stock has sustained its momentum in July so far. Nio put to rest investors' fears about decelerating growth when it released its delivery numbers for May on the first day of June.
GameStop is making significant changes to its workforce, including laying off staff and investing in store managers and employees, according to an internal memo and a source familiar with the matter.
(Bloomberg) — China’s steel mills are sounding the alarm over crisis conditions in the industry as margins plunge due to weak demand. Most Read from BloombergTycoon Whose Bet Broke the Nickel Market Walks Away a BillionaireMusk Tweets About Underpopulation After Report He Fathered Twins With EmployeeBoris Johnson Odds: Who Are the Front-Runners to Replace PM?US Mortgage Rates Plunge to 5.3% in Biggest Drop Since 2008China Considers $220 Billion Stimulus With Unprecedented Bond SalesThe starkest
Yahoo Finance's Brad Smith and Brian Sozzi discuss three other trending news stories today.
The Costco warehouse club has been hesitant to pass on price increases to customers, but two popular menu items in its food court now cost more.
The recent tumble in oil prices amid fears of a global recession begs the question: How low could crude go if major world economies do, in fact, contract? Predictions vary.
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the FDA's authorization of broader access to Pfizer’s COVID-19 pill.
Yahoo Finance food reporter Brooke DiPalma details Amazon's inclusion of GrubHub+ to Prime member exclusive services after the Whole Foods parent company invested a 2 percent stake into the food delivery platform.
WTI oil failed to settle below the psychologically important $100 level and rebounded towards the $105 level.
IONQ LAWSUIT ALERT: Levi & Korsinsky Notifies IonQ, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePR NewswireNEW YORK, July 7, 2022NEW YORK, July 7, 2022 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in IonQ, Inc.
For the U.S. semiconductor industry, certain costs may have to be paid before it is ever able to cash in on its growing political visibility. Chip makers are growing antsy awaiting passage of legislation that would provide about $52 billion in funding for U.S.-based semiconductor-manufacturing operations.
A fact-finding report by Oregon regulators is the latest flash point in the widening fight over the future of natural gas in the region. Ahead of a Public Utility Commission hearing next week on the matter, the ratepayer advocate Oregon CUB on Thursday put out a press release attacking a staff draft of the report for “a lack of clarity and overreliance on industry talking points.” The report is intended to inform Public Utility Commission policymaking as regulated natural gas distribution utilities face compliance with the state’s new Climate Protection Program.
The Wacker Neuson Group will add 200 employees and invest over $10 million in its Menomonee Falls plant after expanding its business with John Deere.